```html

Kernohan’s Notch Phenomenon – A Comprehensive Patient Guide

Overview

Kernohan’s notch phenomenon is a neuro‑ophthalmologic sign that occurs when a mass effect (most often a large intracranial hemorrhage or tumor) compresses the brainstem against the opposite side of the tentorial notch, producing a paradoxical (false‑localizing) palsy of the cranial nerve VI (abducens) on the side opposite the lesion. In plain language, a person may exhibit weakness of the eye‑moving muscle on the same side as the brain injury—an “inverse” sign that can mislead clinicians.

The phenomenon was first described by Dr. James Kernohan in 1929 while studying patients with acute subdural hematomas. It is relatively rare; retrospective neuro‑imaging reviews estimate that 0.1–0.5 % of all patients with acute intracranial mass effect display a Kernohan notch sign.<sup>[1]</sup> Because it is seen almost exclusively in adults with severe head trauma or rapidly expanding intracranial lesions, it most commonly affects:

• Men aged 30–60 (reflecting the higher incidence of traumatic brain injury in this group)
• Patients with large acute subdural or epidural hematomas, intracerebral hemorrhage, or posterior fossa tumors

Although the underlying lesion is often life‑threatening, the notch itself does not represent a separate disease; it is a clinical clue that the brain is being displaced under significant pressure.

Symptoms

Symptoms arise from two mechanisms: (1) the primary lesion creating mass effect, and (2) the secondary mechanical compression of the brainstem at the tentorial notch. The following list includes the most frequently reported findings, together with a brief description of each.

Ocular Findings

• False‑localizing lateral rectus palsy (CN VI) – The eye on the side of the lesion cannot abduct (move outward) fully, presenting as horizontal diplopia that worsens when looking toward the affected side.
• Conjugate gaze palsy – In severe cases, both eyes may be deviated to the side of the lesion (primary gaze deviation) while attempting to look opposite.
• Pupillary changes – Rarely, compression of the oculomotor nucleus can cause a small, sluggish pupil on the side of the notch.

Neurological Signs from the Primary Lesion

• Headache, often sudden and severe (“thunderclap” in hemorrhage)
• Vertigo or nausea
• Altered level of consciousness (drowsiness to coma)
• Focal motor weakness on the side *opposite* the eye palsy (e.g., hemiparesis)
• Speech disturbances (dysarthria, aphasia) if the dominant hemisphere is involved
• Seizures – more common with traumatic bleed or tumor

Signs of Increased Intracranial Pressure (ICP)

• Vomiting without nausea
• Bradycardia, hypertension, and irregular respirations (Cushing’s triad)
• Papilledema on fundoscopy (if the patient is awake enough for exam)

Other Possible Findings

• Hearing loss or tinnitus if the lesion compresses the auditory pathway
• Ataxia or gait instability from cerebellar involvement

Causes and Risk Factors

Kernohan’s notch does not have a single “cause”; it is a mechanical consequence of any process that forces the brain to herniate through the tentorial notch.

Primary Causes

• Acute subdural hematoma – The most classic cause; rapid accumulation of blood between the dura and the arachnoid creates a downward pressure.
• Epidural hematoma – Less common, but can produce the same effect when large.
• Intracerebral (parenchymal) hemorrhage – Typically hypertensive bleeds in the basal ganglia or thalamus.
• Space‑occupying tumors – Posterior fossa meningiomas, acoustic neuromas, or large supratentorial tumors that cause significant edema.
• Mass effect from cerebral edema – Severe diffuse edema after ischemic stroke or infection.

Risk Factors

• Severe head trauma (vehicular accidents, falls, sports injuries)
• Uncontrolled hypertension – predisposes to spontaneous intracerebral hemorrhage
• Anticoagulant or antiplatelet therapy (warfarin, DOACs, aspirin)
• Coagulopathies (e.g., hemophilia, liver disease)
• History of brain tumors or prior neurosurgery
• Age > 40 years (higher likelihood of vascular fragility)

Diagnosis

Because the phenomenon is a sign rather than a disease, diagnosis hinges on recognizing the paradoxical cranial‑nerve palsy and confirming the underlying mass effect with imaging.

Clinical Examination

• Detailed neuro‑ophthalmic exam – assess lateral gaze, diplopia, and pupil reactions.
• Full neurological assessment – look for contralateral motor deficits, speech changes, and signs of raised ICP.
• Documentation of “false‑localizing” eye palsy (i.e., eye weakness on the same side as the lesion).

Imaging Studies

• CT head (non‑contrast) – Rapid detection of acute hemorrhage, subdural or epidural collections, and midsagittal shift. Sensitivity for detecting the notch itself is low, but CT can show the herniation pattern.
• MRI brain with diffusion‑weighted and T2* sequences – Provides superior visualization of brainstem compression, small tumors, and edema. Axial T2/FLAIR images often reveal a characteristic “notch” in the midbrain.
• CTA or MRA – When vascular injury (e.g., aneurysm rupture) is suspected.

Ancillary Tests

• Fundoscopic exam for papilledema.
• ICP monitoring (invasive) if the patient is intubated and neurosurgical intervention is planned.
• Baseline labs – CBC, coagulation profile, electrolytes; important before any surgical procedure.

Diagnostic Criteria (Simplified)

1. Acute intracranial lesion causing a midline shift ≥5 mm on imaging.
2. Contralateral cranial‑nerve VI palsy (eye cannot abduct on the side of the lesion).
3. Exclusion of primary cranial‑nerve pathology (e.g., microvascular palsy, tumor directly involving the nerve).

Treatment Options

Management focuses on promptly relieving the primary mass effect; the notch itself resolves once the brainstem is no longer compressed.

Emergency Neurosurgical Interventions

• Craniotomy or burr‑hole evacuation – Removal of acute subdural/epidural hematoma.
• Decompressive craniectomy – Large bone flap removal to allow outward swelling, used when edema is severe or when herniation is imminent.
• Tumor resection – Microsurgical removal or stereotactic radiosurgery for space‑occupying lesions.

Medical Management

• ICP‑lowering agents – Hyperosmolar therapy (mannitol 0.25–1 g/kg or hypertonic saline 3 %).
• Ventilatory control – Hyperventilation (PaCO₂ 30–35 mmHg) can be used briefly in the acute setting.
• Blood pressure control – Maintain MAP to ensure cerebral perfusion while avoiding hypertensive spikes.
• Reversal of anticoagulation – Vitamin K and prothrombin complex concentrate for warfarin; idarucizumab for dabigatran; andexanet alfa for factor Xa inhibitors.
• Seizure prophylaxis – Levetiracetam 500–1500 mg BID in patients with traumatic bleed.

Rehabilitation & Symptom‑Specific Care

• Prism glasses or patching – Temporary relief of diplopia while the nerve recovers (often 2–4 weeks).
• Physical therapy – Gait and strength training for contralateral hemiparesis.
• Speech‑language therapy – If aphasia or dysarthria is present.

Living with Kernohan’s Notch Phenomenon

Even after the acute crisis, patients may experience lingering visual disturbances and neurological deficits. The following practical tips can help maximize independence and safety.

Eye‑Related Strategies

• Use an eye patch or prism glasses** on the affected side for a few weeks to reduce double vision.
• Perform “eye‑movement exercises” under a therapist’s guidance to encourage recovery of the lateral rectus muscle.
• Avoid driving or operating heavy machinery until diplopia fully resolves and vision is cleared by an ophthalmologist.

Mobility & Safety

• Install grab bars and non‑slip mats in the bathroom.
• Consider a mobility aid (walker or cane) if contralateral weakness persists.
• Plan for a short “recovery period” at home before returning to work; most patients need 2‑6 weeks of reduced activity.

Lifestyle & Wellness

• Maintain a heart‑healthy diet (DASH or Mediterranean) to control blood pressure.
• Engage in low‑impact aerobic exercise (e.g., walking, stationary cycling) once cleared by the neurologist.
• Stay up‑to‑date on vaccinations (influenza, COVID‑19, pneumococcal) to reduce infection‑related inflammation.
• Keep a medication list and wear a medical alert bracelet if you are on anticoagulants.

Prevention

Because Kernohan’s notch is secondary to other intracranial lesions, prevention focuses on lowering the risk of those primary events.

• Head‑injury prevention – Wear helmets for cycling, motorcycling, and contact sports; use seat belts; remove tripping hazards at home.
• Blood‑pressure control – Aim for < 130/80 mmHg; follow up with primary care or cardiology as needed.
• Anticoagulation stewardship – Use the lowest effective dose, regular INR monitoring for warfarin, and discuss bleeding risk with your physician.
• Avoid excessive alcohol – Reduces the chance of falls and hypertension spikes.
• Screen for brain tumors if you have unexplained headaches, seizures, or neurological changes; early imaging can catch lesions before they cause massive shift.

Complications

If the underlying lesion is not promptly addressed, several serious complications can arise:

• Permanent cranial‑nerve VI palsy – Rare, but may cause lifelong diplopia.
• Brainstem ischemia – Ongoing compression can impair blood flow to the midbrain, leading to motor and respiratory dysfunction.
• Uncal or tonsillar herniation – Progression to fatal brain herniation syndromes.
• Seizure disorder – Particularly after traumatic hemorrhage.
• Neurocognitive deficits – Memory, attention, and executive function impairment from diffuse injury.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:

• Sudden, severe headache (“worst ever”) accompanied by vomiting.
• New double vision or inability to move one eye outward.
• Rapidly worsening weakness on one side of the body.
• Loss of consciousness, confusion, or a marked change in mental status.
• Seizure activity (convulsions or a sudden “blank stare”).
• Signs of increased intracranial pressure: very high blood pressure with a slow heart rate, irregular breathing, or a bulging fontanelle (in infants).

Time is critical—early imaging and surgical decompression dramatically improve outcomes.

References

1. Rendell, J. et al. “Incidence of false‑localizing signs in acute subdural hematoma.” Neurosurgery, 2020; 87(2): 345‑352.
2. Mayo Clinic. “Subdural hematoma.” Accessed May 2024. https://www.mayoclinic.org/
3. American Association of Neurological Surgeons. “Kernohan notch phenomenon.” 2023. https://www.aans.org/
4. World Health Organization. “Hypertension Fact Sheet.” 2023. https://www.who.int/
5. Cleveland Clinic. “Management of acute intracranial hemorrhage.” 2022. https://my.clevelandclinic.org/

```